Clinician and patient scores on the SureScore survey for breast cancer and predialysis teams
| Yes (Clinician) | Yes (Patient) | Unsure (Clinician) | Unsure (Patient) | No (Clinician) | No (Patient) | Missing | ||
| Item 1: Did you discuss the treatment option? | BrCa diagnostic consultation | 25 | 25 | 0 | 0 | 0 | 0 | 0 |
| BrCa follow-up consultation | 22 | 22 | 0 | 0 | 0 | 0 | 3 | |
| Predialysis consultation | 26 | 21 | 0 | 0 | 0 | 0 | 5 | |
| Item 2: Did you discuss the risks and benefits of treatment option? | BrCa diagnostic consultation | 22 | 23 | 1 | 0 | 2 | 2 | 0 |
| BrCa follow-up consultation | 24 | 22 | 0 | 0 | 1 | 0 | 3 | |
| Predialysis consultation | 25 | 20 | 1 | 1 | 0 | 0 | 5 | |
| Item 3: Did you discuss what is important in your treatment/to the patient in their treatment? | BrCa diagnostic consultation | 22 | 22 | 0 | 2 | 3 | 1 | 0 |
| BrCa follow-up consultation | 25 | 22 | 0 | 0 | 0 | 0 | 3 | |
| Predialysis consultation | 24 | 20 | 2 | 0 | 0 | 1 | 5 |
BrCa, breast cancer.